New robotic arms from Pittsburgh's RE2 reach for a range of markets
The reach of Pittsburgh�s RE2 continues to grow, both in terms of its business and its robotic manipulator arms.
Make it to the Greater Philadelphia Manufacturing Summit
The Delaware Valley Industrial Resource Center (DVIRC) is hosting the Greater Philadelphia Manufacturing Summit�on Friday, October 3 to demonstrate and the vigor of this essential sector.
Ben Franklin invests $475,000 in five Central PA startups
Ben Franklin Technology Partners of Central and Northern PA is investing $475,000 in five high-tech startups.
AmerisourceBergen expands to Conshohocken; 185 jobs to follow
AmerisourceBergen, a global pharmaceutical services company, is expanding into a new location in Conshohocken and expects to create at least 185 new jobs over the next three years.
Invisible Sentinel and Victory Brewing join forces to defeat the evils of bacteria in beer
Two Philadelphia-area companies, the life-sciences firm Invisible Sentenal and Downingtown-based Victory Brewing Company, have partnered to develop a diagnostic tool to detect beer-spoiling bacteria.
Meet the brains behind Pittsburgh's brightest tech ideas
Discover a whirlwind of mind-blowing possibility during the Pittsburgh Regional Alliance's Tech Crawl.
PA Wilds: Choosing the Commonwealth over Colorado
The couple behind Country Squirrel Outfitters moved their business to Pennsylvania from Colorado thanks to a growing outdoor tourism industry and tight-knit community.
Major solar system will power Urban Outfitters' new center
Urban Outfitters' huge new fulfillment center will feature the largest roof-mounted solar energy system in Pennsylvania and the seventh largest energy system in the state.
Spin-off StratisIS EMS opens another market for Philly's BuLogics
Philadelphia�s rapidly morphing BuLogics has spun off StratisIS EMS, a company that is already profitable, with a growing list of clients and strategic partners.
$35 million in capital is a breath of fresh air for Yardley's OptiNose
Yardley's OptiNose has received $35 million in new capital to continue development of its treatment for serious chronic nasal inflammatory diseases (CNID).